Início do conteúdo
Página Inicial (Inglês)
Developed by researchers at Fiocruz Amazônia, a new trial allows, through the RT-PCR protocol, the screening of the most important Covid-19 virus strains in circulation in Brazil
Fiocruz is part of a project by the Ministry of Health that will sequence samples of the new coronavirus throughout the national territory.
The document opens a bidding process for hiring investors interested in participating in the construction
- Project by Fiocruz Pernambuco on antivirals against Covid-19 is selected in public call
- Fiocruz submits final application for the Covid-19 vaccine registration
- Fiocruz Amazon confirms reinfection by a new variation of the Sars-CoV-2
- Covid-19: Fiocruz takes part in vaccinations at indigenous lands in Amazon
- Covid-19: initiative analyzed 250 thousand hospitalizations in Brazil
- Oxford-Fiocruz vaccine is authorised for emergency use
- Fiocruz publishes technical note on new variation of Sars-CoV-2 in Amazonas
- Nísia Trindade Lima is nominated for second term as president of Fiocruz
- Fiocruz supports alternatives to hasten vaccination in Brazil
- First exposure to the coronavirus may not produce immune memory
- Fiocruz and the British Embassy discuss cooperation
- Project moves forward in the search for therapy to prevent congenital zika syndrome
- Study suggests persistent infection by zika virus in the placenta
- President and researcher at Fiocruz are elected to the Brazilian Academy of Sciences
- Fiocruz confirms the first case of reinfection by the new coronavirus in Brazil
- Fiocruz receives visit from Ambassador of India in Brazil
Photos are part of the historical files of Fiocruz, that keep text documents, maps, films and tapes
See the time line of the most representative events about Covid-19 at Fiocruz
The newsletter of the Fiocruz Global Health Center highlights the latest news about researches, international agreements, courses and more.
Fiocruz is one of the leading institutions on Zika's research. See here some of the newest findings on the theme
Subscribe to Fiocruz International Newsletter
Subscribe and receive our news via email
Fiocruz nas redes sociais
O conteúdo deste portal pode ser utilizado para todos os fins não comerciais, respeitados e reservados os direitos morais dos autores.
